Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
Warning: file_get_contents(http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=21048442&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 445
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Fertility preservation in women with breast cancer Rodriguez-Wallberg KA; Oktay KClin Obstet Gynecol 2010[Dec]; 53 (4): 753-62Fertility preservation is an important issue for young women diagnosed with breast cancer. The most well-established options for fertility preservation in cancer patients, embryo and oocyte cryopreservation, have not been traditionally offered to breast cancer patients as estradiol rise during standard stimulation protocols may not be safe for those patients. Potentially safer stimulation protocols using tamoxifen and aromatase inhibitors induce lower levels of estradiol whereas similar results in terms of number of oocyte and embryo obtained to standard protocols. Cryopreservation of immature oocytes and ovarian cortical tissue, both still experimental methods, are also fertility preservation options for breast cancer patients.|*Fertility[MESH]|Aromatase Inhibitors/therapeutic use[MESH]|Breast Neoplasms/complications/genetics/*therapy[MESH]|Counseling[MESH]|Cryopreservation[MESH]|Embryo, Mammalian[MESH]|Female[MESH]|Gonadotropins/therapeutic use[MESH]|Heterozygote[MESH]|Humans[MESH]|Infertility, Female/*prevention & control[MESH]|Letrozole[MESH]|Nitriles/therapeutic use[MESH]|Oocytes[MESH]|Ovulation Induction[MESH]|Selective Estrogen Receptor Modulators/therapeutic use[MESH]|Tamoxifen/therapeutic use[MESH]|Triazoles/therapeutic use[MESH] |
